J. Voorham

First name
Last name
van Boven, J., Benhaddi, H., Roche, N., Bjermer, L., Miravitlles, M., Voorham, J., & Price, D. (2017). Real-world cost effectiveness comparison of symbicort turbuhaler and duoresp spiromax in UK patients with asthma or chronic obstructive pulmonary disease. Value in Health.
Voorham, J., Roche, N., Benhaddi, H., van der Tol, M., Carter, V., van Boven, J. F. M., et al. (2018). Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022051
Price, D. B., Trudo, F., Voorham, J., Xu, X., Kerkhof, M., Jie, L. Z., & Tran, T. N. (2018). Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. http://doi.org/10.2147/jaa.s176026
Voorham, J., Xu, X., Price, D. B., Golam, S., Davis, J., Ling, Z. J., et al. (2019). Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. http://doi.org/10.1111/all.13556
Kerkhof, M., Voorham, J., Dorinsky, P., Cabrera, C., Darken, P., Kocks, J. W., et al. (2020). Association between COPD exacerbations and lung function decline during maintenance therapy. Thorax. http://doi.org/10.1136/thoraxjnl-2019-214457